State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma

Last updated: January 20, 2026
Sponsor: Baylor College of Medicine
Overall Status: Active - Recruiting

Phase

2

Condition

Post-traumatic Stress Disorders

Treatment

Psilocybin 25mg

Psilocybin 15mg

Clinical Study ID

NCT06888128
H-50300
  • Ages 21-64
  • All Genders

Study Summary

The principal investigator for this study plans to build upon the psilocybin-assisted therapy intervention used in prior completed trials to conduct an open-label trial of two psilocybin administration sessions combined with psychotherapy to investigate the safety, tolerability, and clinical efficacy of psilocybin-assisted therapy for the treatment of PTSD in US Veterans.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Be a United States Military Veteran

  • Have at least a high-school level of education or equivalent (e.g. GED).

  • Have a current DSM-5 diagnosis of Post-traumatic Stress Disorder

  • Have a CAPS-5 total severity score of ≥23 at baseline

  • SSRIs will be allowable so long as participants are on a stable regimen for a periodof 3 months.

  • Concurrent psychotherapy is allowed if the type and frequency of the therapy hasbeen stable for at least 2 months prior to screening and is expected to remainstable during participation in the study.

  • Be medically stable as determined by screening for medical problems via a personalinterview, a medical questionnaire, a physical examination, an electrocardiogram (ECG), and routine medical blood and urinalysis laboratory tests

  • No use of hallucinogens in the past 3 months and no history of regular or frequentuse of hallucinogens

Exclusion

Exclusion Criteria:

  • General medical exclusion criteria:

  • Individuals who are pregnant or nursing; individuals who are of child-bearingpotential and sexually active who are not practicing a highly effective meansof birth control

  • Individuals with partners of childbearing potential who are sexually active andnot practicing a highly effective means of contraception

  • Cardiovascular conditions: coronary artery disease, stroke, angina,uncontrolled hypertension, a clinically significant ECG abnormality (e.g.,atrial fibrilation), prolonged QTc interval (i.e., QTc > 450 msec), artificialheart valve, or TIA in the past year • Systolic blood pressure (SBP) > 139 mmHG; diastolic blood pressure (DBP) > 89 mm HG; heart rate (HR) > 90 bpm.

  • Epilepsy with history of seizures

  • Insulin-dependent diabetes; if taking oral hypoglycemic agent, then no historyof symptoms of hypoglycemia

  • Psychiatric Exclusion Criteria:

  • Current or past history of meeting DSM-5 criteria for schizophrenia spectrum orother psychotic disorders (except substance/medication-induced or due toanother medical condition), or Bipolar I or II Disorder

  • Current or history within six months of meeting DSM-5 criteria for a moderateor severe alcohol, tobacco, caffeine, or other drug use disorder; if a regularsmoker, they must agree to use a nicotine patch on the day of dosing as smokingwill not be allowed on these sessions

  • Have a first degree relative with schizophrenia spectrum or other psychoticdisorders including substance/medication-induced or due to another medicalcondition

  • Risk for acute suicidality as determined by clinician judgment (C-SSRS)

  • Has a psychiatric condition which precludes the establishment of therapeuticrapport as evidenced by long-term patterns of unstable relationships, historyof significant stress-related paranoia, and identity disturbances

  • History of a medically significant suicide attempt

  • Current MAOI antidepressant use

Study Design

Total Participants: 15
Treatment Group(s): 2
Primary Treatment: Psilocybin 25mg
Phase: 2
Study Start date:
January 30, 2025
Estimated Completion Date:
December 15, 2026

Connect with a study center

  • Baylor College of Medicine

    Houston, Texas 77030
    United States

    Site Not Available

  • Baylor College of Medicine

    Houston 4699066, Texas 4736286 77030
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.